I agree that this site is using cookies. You can find further informations here.
X
Stathis, Anastasios
216  results:
Search for persons X
?
1

Targeting CD19-positive lymphomas with the antibody-drug co..:

Tarantelli, Chiara ; Wald, David ; Munz, Nicolas...
Haematologica.  , 2024
Link: https://doi.org/10.3324/..
 
?
2

Antibody-drug conjugates combinations in cancer treatment:

Pretelli, Giulia ; Mati, Kleida ; Motta, Lucia.
Exploration of Targeted Anti-tumor Therapy.  5 (2024)  3 - p. 714-741 , 2024
Link: https://doi.org/10.37349..
 
?
3

IELSG30 phase 2 trial: intravenous and intrathecal CNS prop..:

Conconi, Annarita ; Chiappella, Annalisa ; Ferreri, Andrés J. M....
Blood Advances.  8 (2024)  6 - p. 1541-1549 , 2024
Link: https://doi.org/10.1182/..
 
?
4

Tafasitamab for the treatment of patients with diffuse larg..:

Pirosa, Maria Cristina ; Stathis, Anastasios ; Zucca, Emanuele
Human Vaccines & Immunotherapeutics.  20 (2024)  1 - p. , 2024
Link: https://doi.org/10.1080/..
 
?
5

TLD-1, a novel liposomal doxorubicin, in patients with adva..:

Colombo, Ilaria ; Koster, Kira-Lee ; Holer, Lisa...
European Journal of Cancer.  201 (2024)  - p. 113588 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Population pharmacokinetics of TLD-1, a novel liposomal dox..:

Mc Laughlin, Anna M. ; Hess, Dagmar ; Michelet, Robin...
Cancer Chemotherapy and Pharmacology.  , 2024
Link: https://doi.org/10.1007/..
 
?
7

IELSG38: phase II trial of front-line chlorambucil plus sub..:

Stathis, Anastasios ; Pirosa, Maria Cristina ; Orsucci, Lorella...
Haematologica.  , 2024
Link: https://doi.org/10.3324/..
 
?
8

Clinical outcomes of older and younger patients treated wit..:

Hamadani, Mehdi ; Spira, Alexander ; Zhou, Xiaolei...
Blood Advances.  8 (2023)  1 - p. 93-98 , 2023
Link: https://doi.org/10.1182/..
 
?
9

P1132: LONG-TERM RESPONSES WITH LONCASTUXIMAB TESIRINE: UPD..:

Caimi, Paolo F ; Ai, Weiyun Z ; Pablo Alderuccio, Juan...
HemaSphere.  7 (2023)  S3 - p. e402511c , 2023
Link: https://doi.org/10.1097/..
 
?
10

A Phase I Study of the Pan-Notch Inhibitor CB-103 for Patie..:

Hanna, Glenn J. ; Stathis, Anastasios ; Lopez-Miranda, Elena...
Cancer Research Communications.  3 (2023)  9 - p. 1853-1861 , 2023
Link: https://doi.org/10.1158/..
 
?
11

Safety and anti-tumor activity of lisavanbulin administered..:

Joerger, Markus ; Hundsberger, Thomas ; Haefliger, Simon...
Investigational New Drugs.  41 (2023)  2 - p. 267-275 , 2023
Link: https://doi.org/10.1007/..
 
?
12

Results of an open-label phase 1b study of the ERK inhibito..:

Stathis, Anastasios ; Tolcher, Anthony W. ; Wang, Judy S....
Investigational New Drugs.  41 (2023)  3 - p. 380-390 , 2023
Link: https://doi.org/10.1007/..
 
?
13

Loncastuximab tesirine in relapsed/refractory diffuse large..:

Caimi, Paolo F. ; Ai, Weiyun Z. ; Alderuccio, Juan Pablo...
Haematologica.  , 2023
Link: https://doi.org/10.3324/..
 
?
14

Prognostic implication of PD-L1 in early-stage non-small ce..:

Cekani, Elona ; Martorelli, Carolina ; Martucci, Francesco...
Swiss Medical Weekly.  153 (2023)  9 - p. 40110 , 2023
Link: https://doi.org/10.57187..
 
?
15

The ATR inhibitor elimusertib exhibits anti‐lymphoma activi..:

Sartori, Giulio ; Tarantelli, Chiara ; Spriano, Filippo...
British Journal of Haematology.  204 (2023)  1 - p. 191-205 , 2023
Link: https://doi.org/10.1111/..
 
1-15